DJIA 17,778.15 421.28 2.43%
NASDAQ 4,748.40 104.08 2.24%
S&P 500 2,061.23 48.34 2.40%
market minute promo

AVANIR PHARMACEUTICALS (NASDAQ: AVNR)

16.99 0.07 (0.41%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

AVNR $16.99 0.41%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $16.95
Previous Close $16.92
Daily Range $16.93 - $16.99
52-Week Range $2.62 - $17.05
Market Cap $3.3B
P/E Ratio -54.58
Dividend (Yield) $0.00 (0.0%)
Volume 4,143,464
Average Daily Volume 7,785,689
Current FY EPS -$0.21

Sector

Healthcare

Industry

Drugs

AVANIR PHARMACEUTICALS (AVNR) Description

A pharmaceutical company focused on developing, acquiring and commercializing novel therapeutic products for the treatment of chronic diseases. Website: http://www.avanir.com/

News & Commentary Rss Feed

3 Traits of the Best Healthcare Stocks in 2014

The best healthcare stocks in 2014 saw their shares gain as much as 400% because they exhibited at least one of the following three key traits.

After-Hours Earnings Report for December 10, 2014 : RH, AVNR, CASY, MW, OXM, IRET, CMTL, PPHM, SIGM

After-Hours Earnings Report for December 10, 2014 : RH, AVNR, CASY, MW, OXM, IRET, CMTL, PPHM, SIGM, SURG, CENT, AVNW

Merger Arbitrage Mondays - December 8, 2014

Avanir to be acquired by Otsuka for $3.5 Billion, Shares Up - Analyst Blog

UPDATE: Deutsche Bank Downgrades Avanir Pharmaceuticals, $17 Buyout Target 'Fair'

Avanir Pharmaceuticals, Inc. (AVNR) in Focus: Stock Soars 12.8% - Tale of the Tape

Jim Cramer on the Stock Market: You Have to Love Biotech

Benzinga's M&A Chatter for Tuesday December 2, 2014

Energy Stocks Shake Off Plunging Oil Prices to Push the Dow to New Highs

?Mid-Afternoon Market Update: Avanir Jumps On Otsuka Deal; Mattress Firm Shares Decline

See More AVNR News...

AVNR's Top Competitors

AVNR $16.99 (0.41%)
Current stock: AVNR
JNJ $106.81 (2.63%)
Current stock: JNJ
NVS $94.57 (2.47%)
Current stock: NVS
RHHBY $36.90 (2.39%)
Current stock: RHHBY